Warner Bros. Discovery, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Warner Bros. Discovery, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $10.55B | Mar 1, 2019 |
| FY2018 | Dec 31, 2017 | $6.87B | Mar 1, 2019 |
| FY2018 | Dec 31, 2016 | $6.50B | Mar 1, 2019 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $37.30B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $39.32B | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $41.32B | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $33.82B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $12.19B | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $10.67B | Feb 24, 2023 |
| FY2019 | Dec 31, 2019 | $2.87B | Feb 27, 2020 |
| FY2019 | Sep 30, 2019 | $2.68B | Feb 27, 2020 |
| FY2019 | Jun 30, 2019 | $2.89B | Feb 27, 2020 |
| FY2019 | Mar 31, 2019 | $2.71B | Feb 27, 2020 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $1.86B | Feb 28, 2018 |
| FY2017 | Sep 30, 2017 | $1.65B | Feb 28, 2018 |
| FY2017 | Jun 30, 2017 | $1.75B | Feb 28, 2018 |
| FY2017 | Mar 31, 2017 | $1.61B | Feb 28, 2018 |
| FY2017 | Dec 31, 2016 | $1.67B | Feb 28, 2018 |
| FY2017 | Sep 30, 2016 | $1.56B | Feb 28, 2018 |
| FY2017 | Jun 30, 2016 | $1.71B | Feb 28, 2018 |
| FY2017 | Mar 31, 2016 | $1.56B | Feb 28, 2018 |
| FY2016 | Dec 31, 2015 | $1.65B | Feb 14, 2017 |
| FY2016 | Sep 30, 2015 | $1.56B | Feb 14, 2017 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $727.00M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | ($11.31B) | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | ($3.13B) | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | ($7.37B) | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $1.01B | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $1.22B | Feb 24, 2023 |
| FY2019 | Dec 31, 2019 | $476.00M | Feb 27, 2020 |
| FY2019 | Sep 30, 2019 | $262.00M | Feb 27, 2020 |
| FY2019 | Jun 30, 2019 | $947.00M | Feb 27, 2020 |
| FY2019 | Mar 31, 2019 | $384.00M | Feb 27, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $738.00M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | ($10.03B) | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | ($1.55B) | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | ($7.37B) | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $2.01B | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $2.52B | Feb 24, 2023 |
| FY2019 | Dec 31, 2019 | $705.00M | Feb 27, 2020 |
| FY2019 | Sep 30, 2019 | $619.00M | Feb 27, 2020 |
| FY2019 | Jun 30, 2019 | $911.00M | Feb 27, 2020 |
| FY2019 | Mar 31, 2019 | $774.00M | Feb 27, 2020 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.42B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $9.30B | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $9.70B | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $9.68B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $4.02B | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $2.72B | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $2.79B | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $2.62B | Feb 22, 2021 |
| FY2019 | Dec 31, 2017 | $1.77B | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $1.69B | Mar 1, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.32B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $5.38B | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $7.48B | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $4.30B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $2.80B | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $2.74B | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $3.40B | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $2.58B | Feb 22, 2021 |
| FY2019 | Dec 31, 2017 | $1.63B | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $1.38B | Mar 1, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.23B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $948.00M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $1.32B | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $987.00M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $373.00M | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $402.00M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $289.00M | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $147.00M | Feb 22, 2021 |
| FY2019 | Dec 31, 2017 | $135.00M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $88.00M | Mar 1, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $100.09B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $104.56B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $122.76B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $134.00B | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | $34.43B | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $34.09B | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $33.74B | Feb 22, 2021 |
| FY2019 | Dec 31, 2018 | $32.55B | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $22.56B | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $15.67B | Feb 28, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $62.92B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $69.62B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $76.29B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $85.33B | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | $21.03B | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $21.70B | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $21.77B | Feb 22, 2021 |
| FY2019 | Dec 31, 2018 | $22.03B | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $17.53B | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $10.26B | Feb 28, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $35.92B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $34.04B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $45.23B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $47.10B | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | $11.60B | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $10.46B | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $9.89B | Feb 22, 2021 |
| FY2019 | Dec 31, 2018 | $8.39B | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $4.61B | Mar 1, 2019 |
| FY2015 | Dec 31, 2015 | $5.45B | Feb 18, 2016 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $25.93B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $25.67B | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $34.97B | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $34.44B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $12.91B | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $13.07B | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $13.05B | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $13.01B | Feb 22, 2021 |
| FY2019 | Dec 31, 2017 | $7.07B | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $8.04B | Mar 1, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($11.51B) | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | ($12.24B) | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | ($928.00M) | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $2.21B | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | $9.58B | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $8.54B | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $7.33B | Feb 22, 2021 |
| FY2019 | Dec 31, 2018 | $5.25B | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $4.63B | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $5.23B | Feb 28, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.57B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $5.31B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $3.78B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $3.73B | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | $3.91B | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $2.09B | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $1.55B | Feb 22, 2021 |
| FY2019 | Dec 31, 2018 | $986.00M | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $7.31B | Mar 1, 2019 |
| FY2018 | Dec 31, 2016 | $300.00M | Mar 1, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $32.57B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $39.51B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $43.67B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $49.00B | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | $14.76B | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $15.40B | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $15.42B | Feb 22, 2021 |
| FY2019 | Dec 31, 2018 | $16.79B | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $14.79B | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $7.92B | Feb 28, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | (4) | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | (1) | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | (3) | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | 1 | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | 1 | Feb 24, 2023 |
| FY2014 | Dec 31, 2014 | 0 | Feb 19, 2015 |
| FY2014 | Sep 30, 2014 | 0 | Feb 19, 2015 |
| FY2014 | Jun 30, 2014 | 0 | Feb 19, 2015 |
| FY2014 | Mar 31, 2014 | 0 | Feb 19, 2015 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | (4) | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | (1) | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | (3) | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | 1 | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | 1 | Feb 24, 2023 |
| FY2014 | Dec 31, 2014 | 0 | Feb 19, 2015 |
| FY2014 | Sep 30, 2014 | 0 | Feb 19, 2015 |
| FY2014 | Jun 30, 2014 | 0 | Feb 19, 2015 |
| FY2014 | Mar 31, 2014 | 0 | Feb 19, 2015 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2.48B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 2.45B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | 2.44B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | 2.43B | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | 169.00M | Feb 24, 2023 |